Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Batch Reconciliation in Transdermal Patches Production

Posted on By

SOP for Batch Reconciliation in Transdermal Patches Production

Standard Operating Procedure for Batch Reconciliation in Transdermal Patches Production

1) Purpose

The purpose of this SOP is to establish procedures for conducting batch reconciliation during the production of transdermal patches to ensure accuracy and completeness of manufacturing records.

2) Scope

This SOP applies to batch reconciliation activities performed after completion of each batch of transdermal patches within the production area.

3) Responsibilities

The Production Department is responsible for executing batch reconciliation as per this SOP. Quality Assurance (QA) personnel may oversee and verify reconciliation activities.

4) Procedure

4.1 Initial Preparation

  • 4.1.1 Collect all relevant batch records, production logs, and documentation pertaining to the completed batch of transdermal patches.
  • 4.1.2 Ensure batch records are accurate, complete, and signed off by responsible personnel at each stage of production.
See also  SOP for Specific Gravity Testing in Transdermal Patches

4.2 Components and Materials Reconciliation

  • 4.2.1 Verify reconciliation of raw materials and packaging components used against the quantities documented in batch records.
  • 4.2.2 Record any discrepancies found during reconciliation and investigate root causes as per established procedures.

4.3 In-Process and Finished Product Inventory

  • 4.3.1 Compare in-process inventory quantities (e.g., semi-finished patches) documented in batch records with physical counts.
  • 4.3.2 Conduct final reconciliation of finished product units manufactured against the expected output documented in batch records.

4.4 Documentation Review

  • 4.4.1 Review all batch records, reconciliation reports, and related documentation for accuracy and completeness.
  • 4.4.2 Ensure that any deviations or discrepancies identified during reconciliation are documented and investigated according to deviation handling procedures.
See also  SOP for Preventing Contamination in Transdermal Patches Production

4.5 Approval and Release

  • 4.5.1 Obtain approval from authorized personnel for batch reconciliation and release of transdermal patches for further processing or packaging.
  • 4.5.2 Archive reconciled batch records and associated documentation in accordance with established record retention policies.

5) Abbreviations, if any

SOP: Standard Operating Procedure
QA: Quality Assurance

6) Documents, if any

Batch Records
Reconciliation Reports
Deviation Investigation Reports

7) Reference, if any

ICH Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients
ISO 13485: Medical devices – Quality management systems

8) SOP Version

Version 1.0

Transdermal Patches Tags:Adhesion Testing Protocol, Analytical Method Development SOP, Assay of Active Ingredient SOP, Contamination Prevention SOP, Documentation SOP, Equipment calibration SOP, Equipment Cleaning SOP, Final Product Inspection SOP, Formulation development SOP, Homogeneity Testing SOP, In-process Testing SOP, Microbial Testing SOP, Personnel Training SOP, Process Optimization SOP, Process Validation SOP, Quality Control Transdermal Patches, Raw Material Inspection SOP, Release Rate Testing SOP, Sample Collection SOP, Sterility Maintenance SOP, Storage Conditions Transdermal Patches, Thickness Testing Procedure, Transdermal Patch Manufacturing SOP, Transdermal Patch Stability Testing, Waste Handling SOP

Post navigation

Previous Post: SOP for Pharmacovigilance Regulatory Submission
Next Post: SOP for Batch Manufacturing Record for Transdermal Patches

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version